Published in J Biol Chem on May 29, 1998
Risk factors for venous and arterial thrombosis. Blood Transfus (2010) 1.58
Altered fibroblast proteoglycan production in COPD. Respir Res (2010) 1.14
Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase. J Cell Biol (2003) 1.11
Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells. Clin Exp Metastasis (2003) 1.08
Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J (2002) 1.07
Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling. J Biol Chem (2009) 1.07
A single mutation in the E2 glycoprotein important for neurovirulence influences binding of sindbis virus to neuroblastoma cells. J Virol (2002) 1.07
Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. J Biol Chem (2008) 1.04
'Heparin'--from anticoagulant drug into the new biology. Glycoconj J (2001) 1.01
The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H? J Innate Immun (2013) 0.96
Age-related differences in human skin proteoglycans. Glycobiology (2010) 0.96
Apolipoprotein E and cholesterol in aging and disease in the brain. Future Lipidol (2008) 0.94
Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix. J Biol Chem (2009) 0.92
Glycosaminoglycan-lipoprotein interaction. Glycoconj J (2001) 0.90
Oxidation of heparan sulphate by hypochlorite: role of N-chloro derivatives and dichloramine-dependent fragmentation. Biochem J (2005) 0.88
Overgrowth syndromes and the regulation of signaling complexes by proteoglycans. Am J Hum Genet (1999) 0.86
The proteoglycan glycomatrix: a sugar microenvironment essential for complement regulation. Front Immunol (2013) 0.84
Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement Regulation. Front Immunol (2015) 0.84
Role of Factor H and Related Proteins in Regulating Complement Activation in the Macula, and Relevance to Age-Related Macular Degeneration. J Clin Med (2015) 0.83
ELECTRON DETACHMENT DISSOCIATION OF SYNTHETIC HEPARAN SULFATE GLYCOSAMINOGLYCAN TETRASACCHARIDES VARYING IN DEGREE OF SULFATION AND HEXURONIC ACID STEREOCHEMISTRY. Int J Mass Spectrom (2012) 0.82
Role of heparan sulfate in ocular diseases. Exp Eye Res (2013) 0.82
Sulphation heterogeneity in the trisaccharide (GalNAcSbeta1, 4GlcAbeta1,3GalNAcS) isolated from the non-reducing terminal of human aggrecan chondroitin sulphate. Biochem J (1999) 0.81
Method development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes. Anal Chem (2013) 0.81
Role of 6-O-sulfated heparan sulfate in chronic renal fibrosis. J Biol Chem (2014) 0.79
Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol (2014) 0.77
The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate. Glycoconj J (2016) 0.77
Proinflammation of aging central arteries: a mini-review. Gerontology (2014) 0.76
Glycomics approaches for the bioassay and structural analysis of heparin/heparan sulphates. Metabolites (2012) 0.76
An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure. Glycoconj J (2016) 0.75
Dynamic changes in heparan sulfate during muscle differentiation and ageing regulate myoblast cell fate and FGF2 signalling. Matrix Biol (2016) 0.75
Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting. Front Mol Biosci (2016) 0.75
Vertebral artery thrombosis: a rare presentation of primary polycythaemia. BMJ Case Rep (2014) 0.75
Proteoglycans: structures and interactions. Annu Rev Biochem (1991) 6.53
Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev (1994) 5.66
Molecular diversity of heparan sulfate. J Clin Invest (2001) 5.40
Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem (1978) 4.51
A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci U S A (1992) 2.92
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci U S A (1980) 2.61
Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum (1986) 2.56
The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem (1998) 2.47
High incidence of post-injury pneumonia in intensive care-treated trauma patients. Acta Anaesthesiol Scand (2013) 2.46
Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett (1976) 2.34
Heparan sulfate: a piece of information. FASEB J (1996) 2.33
Biosynthesis of heparin. II. Formation of sulfamino groups. J Biol Chem (1973) 2.27
Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem (1993) 2.23
A proteoglycan form of heparin and its degradation to single-chain molecules. J Biol Chem (1978) 2.18
Structure of the antithrombin-binding site in heparin. Proc Natl Acad Sci U S A (1979) 2.08
Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem (1993) 2.07
The molecular-weight-dependence of the anti-coagulant activity of heparin. Biochem J (1978) 2.03
T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol (1985) 1.96
Defining the interleukin-8-binding domain of heparan sulfate. J Biol Chem (1998) 1.93
Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum (1986) 1.90
Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem (2001) 1.89
Heparin-lipoprotein lipase interactions. Fed Proc (1977) 1.87
Domain structure of heparan sulfates from bovine organs. J Biol Chem (1996) 1.84
Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res (1982) 1.83
Mechanism of the anticoagulant action of heparin. Mol Cell Biochem (1982) 1.80
Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) (2007) 1.71
An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J (1996) 1.68
Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem (2001) 1.68
Human endogenous proviruses. Curr Top Microbiol Immunol (1989) 1.68
Induced expression of syndecan in healing wounds. J Cell Biol (1991) 1.67
Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences. J Virol (1987) 1.59
Distribution of sulphate and iduronic acid residues in heparin and heparan sulphate. Biochem J (1974) 1.59
Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Immunol (1983) 1.58
Glycosaminoglycans and the regulation of blood coagulation. Biochem J (1993) 1.57
Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem (1984) 1.56
The chondroitin 4-sulfate-protein linkage. J Biol Chem (1966) 1.55
Attempted isolation of a heparin proteoglycan from bovine liver capsule. Biochem J (1970) 1.53
Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase. J Biol Chem (1979) 1.53
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem J (1984) 1.49
Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J Gen Virol (1991) 1.49
Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem (1998) 1.47
Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. J Biol Chem (1984) 1.46
Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet (1988) 1.46
Identification of N-sulphated disaccharide units in heparin-like polysaccharides. Biochem J (1979) 1.44
Further characterization of the heparin-protein linkage region. Biochim Biophys Acta (1966) 1.44
Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem (1999) 1.42
The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. EMBO Rep (2000) 1.41
Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology (1988) 1.41
Trauma patients in the ICU need antimicrobial prophylaxis to prevent pneumonia: in reply. Acta Anaesthesiol Scand (2014) 1.39
Arterial hypotension and hypoxaemia during total hip replacement: the importance of thromboplastic products, fat embolism and acrylic monomers. Acta Anaesthesiol Scand (1975) 1.39
Biosynthesis of heparin. Concerted action of late polymer-modification reactions. J Biol Chem (1980) 1.38
Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J (1999) 1.38
Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans. J Biol Chem (1987) 1.38
N-[3H]Acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans. Anal Biochem (1982) 1.37
Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J Biol Chem (1997) 1.35
Formation and growth of multicellular spheroids of human origin. Int J Cancer (1983) 1.35
Non-muscle alpha-dystroglycan is involved in epithelial development. J Cell Biol (1995) 1.34
Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer (1981) 1.33
Role of extradural and of general anaesthesia in fibrinolysis and coagulation after total hip replacement. Br J Anaesth (1983) 1.33
Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. Biochem J (1980) 1.33
Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma. J Biol Chem (1975) 1.32
Evidence for an ionic binding of lipoprotein lipase to heparin. Biochem Biophys Res Commun (1971) 1.32
Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J Biol Chem (2000) 1.31
Identification of iduronic acid as the major sulfated uronic acid of heparin. J Biol Chem (1971) 1.30
Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development (1995) 1.30
Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis. Proc Natl Acad Sci U S A (2001) 1.26
Anticoagulant activity of heparin: isolation of antithrombin-binding sites. FEBS Lett (1976) 1.26
Cell-type-specific pattern of myc protooncogene expression in developing human embryos. Proc Natl Acad Sci U S A (1985) 1.26
Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans. Biochem J (1988) 1.26
Biosynthesis of L-iduronic acid in heparin: epimerization of D-glucuronic acid on the polymer level. Biochem Biophys Res Commun (1972) 1.25
The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group. J Biol Chem (1983) 1.24
The effect of heparin on the inositol 1,4,5-trisphosphate receptor in rat liver microsomes. Dependence on sulphate content and chain length. FEBS Lett (1989) 1.23
Trends in microvascular research. The microembolism syndrome. Microvasc Res (1976) 1.23
Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells. J Biol Chem (1985) 1.23
Biosynthesis of heparan sulfate. Coordination of polymer-modification reactions in a Chinese hamster ovary cell mutant defective in N-sulfotransferase. J Biol Chem (1991) 1.23
Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase. Biochemistry (2001) 1.22
The molecular size of the antithrombin-binding sequence in heparin. FEBS Lett (1980) 1.21
Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol (2003) 1.21
Biosynthesis of heparin. 3. Formation of iduronic acid residues. J Biol Chem (1974) 1.20
The structures of xylosylserine and galactosylxylosylserine from heparin. Biochim Biophys Acta (1966) 1.19
Glycosaminoglycans in rat mucosal mast cells. Biochem J (1985) 1.19
Biosynthesis of heparin. Studies on the microsomal sulfation process. J Biol Chem (1975) 1.19
Occurrence and biosynthesis of beta-glucuronidic linkages in heparin. J Biol Chem (1971) 1.18
Binding of human syndecan to extracellular matrix proteins. J Biol Chem (1990) 1.17
Biosynthesis of heparin. Loss of C-5 hydrogen during conversion of D-glucuronic to L-iduronic acid residues. Biochem Biophys Res Commun (1976) 1.17
Biosynthesis of heparin. Purification of a 110-kDa mouse mastocytoma protein required for both glucosaminyl N-deacetylation and N-sulfation. J Biol Chem (1991) 1.17
Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem (1997) 1.16
Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol (1999) 1.15
Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem (1995) 1.15
Degradation of heparin in mouse mastocytoma tissue. Biochem J (1971) 1.14
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5. Carbohydr Res (1994) 1.13
Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. J Biol Chem (1986) 1.13
Mode of degradation of the chondroitin sulphate proteoglycan in rat costal cartilage. Biochem J (1972) 1.13
Structure and biosynthesis of heparin-like polysaccharides. Fed Proc (1977) 1.12
Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem (1996) 1.12
Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation (2000) 1.12